© 2003 by Oxford University Press
© 2003 Oxford University Press
ARTICLE |
Prostate Carcinogenesis in N-methyl-N-nitrosourea (NMU)-Testosterone-Treated Rats Fed Tomato Powder, Lycopene, or Energy-Restricted Diets
Affiliations of authors: Division of Nutritional Sciences, University of Illinois, Urbana-Champaign, IL (TWMB, JWE); Division of Hematology and Oncology, Department of Internal Medicine, James Cancer Hospital and Solove Research Institute (ZL, SKC), School of Public Health (SL), Center for Biostatistics (SK), and Department of Human Nutrition (SKC), The Ohio State University, Columbus, OH.
Correspondence to: Steven K. Clinton, MD, PhD, A434 Starling Loving Hall, 320 West 10th Ave., The Ohio State University, Columbus, OH 43210 (e-mail: clinton-1{at}medctr.osu.edu).
Background: Consumption of tomato products or lycopene and energy restriction have been hypothesized to reduce the risk of human prostate cancer. We investigated the effects of these dietary variables in a rat model of prostate carcinogenesis. Methods: Male rats (n = 194) treated with N-methyl-N-nitrosourea and testosterone to induce prostate cancer were fed diets containing whole tomato powder (13 mg lycopene/kg diet), lycopene beadlets (161 mg lycopene/kg diet), or control beadlets. Rats in each group were randomly assigned to either ad libitum feeding or 20% diet restriction. Differences between Kaplan-Meier survival curves for diet composition or restriction were tested with the log-rank test. Cox proportional hazards models were developed to examine the combined effect of diet composition and restriction on survival. Statistical tests were two-sided. Results: Risk of death with prostate cancer was lower for rats fed the tomato powder diet than for rats fed control beadlets (hazard ratio [HR] = 0.74, 95% confidence interval [CI] = 0.59 to 0.93; P = .009). In contrast, prostate cancer-specific mortality of the control and lycopene-fed rats was similar (P = .63). The proportions of rats dying with prostate cancer in the control, lycopene, and tomato powder groups were 80% (95% CI = 68% to 89%), 72% (95% CI = 60% to 83%), and 62% (95% CI = 48% to 75%), respectively. Rats in the diet-restricted group experienced longer prostate cancer-free survival than rats in the ad libitum-fed group (HR = 0.68, 95% CI = 0.49 to 0.96; P = .029). The proportion of rats that developed prostate cancer was 79% (95% CI = 69% to 86%) for ad libitum-fed rats and 65% (95% CI = 54% to 74%) for rats fed restricted diets. No interactions were observed between diet composition and dietary restriction. Conclusions: Consumption of tomato powder but not lycopene inhibited prostate carcinogenesis, suggesting that tomato products contain compounds in addition to lycopene that modify prostate carcinogenesis. Diet restriction also reduced the risk of prostate cancer. Tomato phytochemicals and diet restriction may act by independent mechanisms.
Correspondence about this Article
- Re: Prostate Carcinogenesis in N-methyl-N-nitrosourea (NMU)Testosterone-Treated Rats Fed Tomato Powder, Lycopene, or Energy-Restricted Diets
- Jacqueline Limpens, Wytske M. van Weerden, Klaus Krämer, Dirk Pallapies, Ute C. Obermüller-Jevic, and Fritz H. Schröder
J Natl Cancer Inst 2004 96: 554.[Extract] [Full Text] [PDF]
- RESPONSE: Re: Prostate Carcinogenesis in N-methyl-N-nitrosourea (NMU)Testosterone-Treated Rats Fed Tomato Powder, Lycopene, or Energy-Restricted Diets
- Steven K. Clinton, Thomas M.-W. Boileau, and John W. Erdman, Jr.
J Natl Cancer Inst 2004 96: 554-555.[Extract] [Full Text] [PDF]
Editorial about this Article
- Tomatoes or Lycopene Versus Prostate Cancer: Is Evolution Anti-Reductionist?
- Peter H. Gann and Frederick Khachik
J Natl Cancer Inst 2003 95: 1563-1565.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
![]() |
J. Jayachandran and S. J. Freedland Prevention of Prostate Cancer: What We Know and Where We Are Going American Journal of Men's Health, June 1, 2008; 2(2): 178 - 189. [Abstract] [PDF] |
||||
![]() |
V. V. Mossine, P. Chopra, and T. P. Mawhinney Interaction of Tomato Lycopene and Ketosamine against Rat Prostate Tumorigenesis Cancer Res., June 1, 2008; 68(11): 4384 - 4391. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Davis Nutritional Interactions: Credentialing of Molecular Targets for Cancer Prevention Experimental Biology and Medicine, February 1, 2007; 232(2): 176 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Canene-Adams, B. L. Lindshield, S. Wang, E. H. Jeffery, S. K. Clinton, and J. W. Erdman Jr. Combinations of Tomato and Broccoli Enhance Antitumor Activity in Dunning R3327-H Prostate Adenocarcinomas Cancer Res., January 15, 2007; 67(2): 836 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Campbell, C. K. Stroud, M. T. Nakamura, M. A. Lila, and J. W. Erdman Jr. Serum Testosterone Is Reduced Following Short-Term Phytofluene, Lycopene, or Tomato Powder Consumption in F344 Rats J. Nutr., November 1, 2006; 136(11): 2813 - 2819. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Nantz, C. A. Rowe, C. Nieves Jr., and S. S. Percival Immunity and Antioxidant Capacity in Humans Is Enhanced by Consumption of a Dried, Encapsulated Fruit and Vegetable Juice Concentrate J. Nutr., October 1, 2006; 136(10): 2606 - 2610. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Limpens, F. H. Schroder, C. M. A. de Ridder, C. A. Bolder, M. F. Wildhagen, U. C. Obermuller-Jevic, K. Kramer, and W. M. van Weerden Combined Lycopene and Vitamin E Treatment Suppresses the Growth of PC-346C Human Prostate Cancer Cells in Nude Mice J. Nutr., May 1, 2006; 136(5): 1287 - 1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zaripheh, T. Y. Nara, M. T. Nakamura, and J. W. Erdman Jr. Dietary Lycopene Downregulates Carotenoid 15,15'-Monooxygenase and PPAR-{gamma} in Selected Rat Tissues J. Nutr., April 1, 2006; 136(4): 932 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Adams, N. P. Seeram, M. L. Hardy, C. Carpenter, and D. Heber Analysis of the Interactions of Botanical Extract Combinations Against the Viability of Prostate Cancer Cell Lines Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 117 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Kirsh, S. T. Mayne, U. Peters, N. Chatterjee, M. F. Leitzmann, L. B. Dixon, D. A. Urban, E. D. Crawford, and R. B. Hayes A Prospective Study of Lycopene and Tomato Product Intake and Risk of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 92 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Freedland Obesity and Prostate Cancer: A Growing Problem Clin. Cancer Res., October 1, 2005; 11(19): 6763 - 6766. [Full Text] [PDF] |
||||
![]() |
M. Pollard and M. A. Suckow Hormone-Refractory Prostate Cancer in the Lobund-Wistar Rat Experimental Biology and Medicine, September 1, 2005; 230(8): 520 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zaripheh and J. W. Erdman Jr. The Biodistribution of a Single Oral Dose of [14C]-Lycopene in Rats Prefed Either a Control or Lycopene-Enriched Diet J. Nutr., September 1, 2005; 135(9): 2212 - 2218. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Davis, C. A. Swanson, R. G. Ziegler, B. Clevidence, J. T. Dwyer, and J. A. Milner Executive Summary Report J. Nutr., August 1, 2005; 135(8): 2014S - 2029S. [Full Text] [PDF] |
||||
![]() |
S. K. Clinton Tomatoes or Lycopene: a Role in Prostate Carcinogenesis? J. Nutr., August 1, 2005; 135(8): 2057S - 2059S. [Full Text] [PDF] |
||||
![]() |
A. H. Lichtenstein and R. M. Russell Essential Nutrients: Food or Supplements?: Where Should the Emphasis Be? JAMA, July 20, 2005; 294(3): 351 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. FINLEY Proposed Criteria for Assessing the Efficacy of Cancer Reduction by Plant Foods Enriched in Carotenoids, Glucosinolates, Polyphenols and Selenocompounds Ann. Bot., June 1, 2005; 95(7): 1075 - 1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Canene-Adams, J. K. Campbell, S. Zaripheh, E. H. Jeffery, and J. W. Erdman Jr The Tomato As a Functional Food J. Nutr., May 1, 2005; 135(5): 1226 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Campbell, K. Canene-Adams, B. L. Lindshield, T. W.-M. Boileau, S. K. Clinton, and J. W. Erdman Jr Tomato Phytochemicals and Prostate Cancer Risk J. Nutr., December 1, 2004; 134(12): 3486S - 3492S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Limpens, W. M. van Weerden, K. Kramer, D. Pallapies, U. C. Obermuller-Jevic, and F. H. Schroder Re: Prostate Carcinogenesis in N-methyl-N-nitrosourea (NMU)-Testosterone-Treated Rats Fed Tomato Powder, Lycopene, or Energy-Restricted Diets J Natl Cancer Inst, April 7, 2004; 96(7): 554 - 554. [Full Text] [PDF] |
||||
![]() |
P. H. Gann and F. Khachik Tomatoes or Lycopene Versus Prostate Cancer: Is Evolution Anti-Reductionist? J Natl Cancer Inst, November 5, 2003; 95(21): 1563 - 1565. [Full Text] [PDF] |
||||









